[Plasmapheresis in a case of necessary discontinuation of cyclophosphamide in the treatment of severe lupus nephritis].
On the basis of a 61 years old patient with severe lupus nephritis, we present effective use of plasmapheresis added to the standard immunosuppressive therapy with methylprednisolone and cyclophosphamide. In the paper, attention was paid to the usefulness of plasmapheresis both because of severe course of the disease as well as the necessary discontinuation of immunosuppressive therapy because of its severe side effects.
Saracyn
Marek
M
Wojskowy Instytut Medyczny, Klinika Nefrologii ze Stacja Dializ CSK MON w Warszawie. msaracyn@wim.mil.pl
Korsak
Jolanta
J
Wańkowicz
Zofia
Z
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage* / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D008181:Lupus Nephritis / Q000188:drug therapy / Q000628:therapy*; D008775:Methylprednisolone / Q000008:administration & dosage; D008875:Middle Aged; D010956:Plasmapheresis; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D008775:Methylprednisolone